Back
ClearPoint Neuro Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
CLPT
ClearPoint Neuro
Last Price:
11.10
Seasonality Move:
21.75%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...ClearPoint Neuro Price Quote
$11.10
+0.14 (+1.28%)
(Updated: November 21, 2024 at 5:55 PM ET)
ClearPoint Neuro Key Stats
Sell
22
ClearPoint Neuro (CLPT)
is a Sell
Day range:
$10.60 - $11.05
52-week range:
$5.11 - $14.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.28
P/B ratio:
10.22%
Volume:
148K
Avg. volume:
260K
1-year change:
88.15%
Market cap:
$296.3M
Revenue:
$24M
EPS:
$-0.69
How Much Does ClearPoint Neuro Make?
-
How Much Are ClearPoint Neuro's Sales Annually?
CLPT Revenues are $24M -
How Much Profit Does ClearPoint Neuro's Make A Year?
CLPT net income is -$22.1M
Is ClearPoint Neuro Growing As A Company?
-
What Is ClearPoint Neuro's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.41% -
What Is ClearPoint Neuro's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ClearPoint Neuro Stock Price Performance
-
Did ClearPoint Neuro Stock Go Up Last Month?
ClearPoint Neuro share price went down by -18.57% last month -
Did CLPT's Share Price Rise Over The Last Year?
CLPT share price rose by 88.15% over the past 1 year
What Is ClearPoint Neuro 52-Week High & Low?
-
What Is ClearPoint Neuro’s 52-Week High Share Price?
ClearPoint Neuro has traded as high as $14.13 over the past 52 weeks -
What Is ClearPoint Neuro’s 52-Week Low Share Price?
ClearPoint Neuro has traded as low as $5.11 over the past 52 weeks
ClearPoint Neuro Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ClearPoint Neuro?
-
How Much Debt Does ClearPoint Neuro Have?
Total long term debt quarterly is $0 -
How Much Cash Does ClearPoint Neuro Have?
Cash and short term investments quarterly total is $21.6M -
What Is ClearPoint Neuro’s Book Value Per Share?
Book value per share is 1.05
Is ClearPoint Neuro Cash Flow Positive?
-
What Is CLPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.9M -
What Is ClearPoint Neuro’s Cash Flow From Financing?
Cash flow from financing (TTM) is $6.3M -
What Is ClearPoint Neuro’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$200K
ClearPoint Neuro Return On Invested Capital
-
Is Management Doing A Good Job?
CLPT return on invested capital is -50.18% -
What Is ClearPoint Neuro Return On Assets?
ROA measures how assets are converting to revenues and is -38.96% -
What Is CLPT Return On Equity?
ROE is a measure of profitability and is -64.36%
ClearPoint Neuro Earnings Date & Stock Price
-
What Is ClearPoint Neuro's Stock Price Today?
A single share of CLPT can be purchased today for 10.96 -
What Is ClearPoint Neuro’s Stock Symbol?
ClearPoint Neuro trades on the nasdaq under the ticker symbol: CLPT -
When Is ClearPoint Neuro’s Next Earnings Date?
The next quarterly earnings date for ClearPoint Neuro is scheduled on March 12, 2025 -
When Is CLPT's next ex-dividend date?
ClearPoint Neuro's next ex-dividend date is November 22, 2024 -
How To Buy ClearPoint Neuro Stock?
You can buy ClearPoint Neuro shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ClearPoint Neuro Competitors
-
Who Are ClearPoint Neuro's Competitors?
Below is a list of companies who compete with ClearPoint Neuro or are related in some way:
ClearPoint Neuro Dividend Yield
-
What Is CLPT Dividend Yield?
ClearPoint Neuro’s dividend yield currently is 0% -
What Is ClearPoint Neuro’s Payout Ratio?
ClearPoint Neuro’s payout ratio is 0% -
When Did ClearPoint Neuro Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is ClearPoint Neuro’s Dividend Per Share?
ClearPoint Neuro pays a dividend of $0.00 per share
ClearPoint Neuro Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -3.85% |
| Revenue: | 40.96% | 4.4% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 16.33 |
| Upside from Last Price: | 49.03% |